Objectives: This study evaluates the feasibility and safety of open-partial nephrectomies in the ZIRK-technique (Zero Ischemia Resection in the Kidney) for renal masses with high-risk anatomical features - objectified by the PADUA score. Methods: We identified 40 consecutive cases of partial nephrectomies performed without clamping of the renal artery in our department of urology. Retrospective analysis of the preoperative CT or MRI scans showed 27 cases with a PADUA score ≥8, of which 15 cases had a score ≥10. Cases were in particular assessed regarding operation time (ORT), estimated blood loss (EBL), surgical margins and postoperative complications using the Clavien classification. Results: The mean age of the study population was 67.6 years with an average BMI of 26.8 kg/m2. The mean ORT was 1:46 with an average EBL of 521 ml. Clavien grade II complications were observed seven times, while 3 patients had a grade IIIa complication. Despite complex and adverse location of the tumors, nephron-sparing surgery without ischemia could be performed with negative surgical margins for all cases. EBL, transfusion rate and complication were considerably more frequent in high-risk tumors. Conclusion: Highly complex renal tumors, PADUA ≥10, can be resected in ZIRK-technique with good operative outcome and a low complication rate.

Keywords:
Nephron-sparing surgery, PADUA, Open-partial nephrectomy, Zero ischemia
1.
Patard JJ, Rodriguez A, Rioux-Leclercq N, Guillé F, Lobel B: Prognostic significance of the mode of detection in renal tumours. BJU Int 2002;90:358-363.
2.
Zastrow S, Phuong A, von Bar I, Novotny V, Hakenberg OW, Wirth MP: Primary tumor size in renal cell cancer in relation to the occurrence of synchronous metastatic disease. Urol Int 2014;92:462-467.
3.
Minervini A, Serni S, Carini M: Words of wisdom. Re: partial nephrectomy versus radical nephrectomy in patients with small renal tumors - is there a difference in mortality and cardiovascular outcomes? Eur Urol 2009;56:740-741.
4.
Gratzke C, Seitz M, Bayrle F, Schlenker B, Bastian PJ, Haseke N, et al: Quality of life and perioperative outcomes after retroperitoneoscopic radical nephrectomy (RN), open RN and nephron-sparing surgery in patients with renal cell carcinoma. BJU Int 2009;104:470-475.
5.
Krebs RK, Andreoni C, Ortiz V: Impact of radical and partial nephrectomy on renal function in patients with renal cancer. Urol Int 2014;92:449-454.
6.
Lane BR, Babineau DC, Poggio ED, Weight CJ, Larson BT, Gill IS, et al: Factors predicting renal functional outcome after partial nephrectomy. J Urol 2008;180:2363-2368.
7.
Thompson RH, Lane BR, Lohse CM, Leibovich BC, Fergany A, Frank I, et al: Comparison of warm ischemia versus no ischemia during partial nephrectomy on a solitary kidney. Eur Urol 2010;58:331-336.
8.
Thompson RH, Lane BR, Lohse CM, Leibovich BC, Fergany A, Frank I, et al: Every minute counts when the renal hilum is clamped during partial nephrectomy. Eur Urol 2010;58:340-345.
9.
Krane LS, Mufarrij PW, Manny TB, Hemal AK: Comparison of clamping technique in robotic partial nephrectomy: does unclamped partial nephrectomy improve perioperative outcomes and renal function? Can J Urol 2013;20:6662-6667.
10.
Akca O, Zargar HS, Brandao LF, Laydner H, Autorino R, Krishnan J, et al: MP54-13: the effects of prolonged warm ischemia on late renal function after robotic partial nephrectomy. J Urol 2014;191(suppl 4):e577.
11.
Shah P, Alom M, George A, Kavoussi L, Richstone L, Moreira D, et al: MP64-19: off-clamp laparoscopic partial nephrectomy: long term renal functional outcomes. J Urol 2014;191(suppl 4):e707-e708.
12.
Ng CK, Gill IS, Patil MB, Hung AJ, Berger AK, de Castro Abreu AL, et al: Anatomic renal artery branch microdissection to facilitate zero-ischemia partial nephrectomy. Eur Urol 2012;61:67-74.
13.
Peña JA, Oliveira M, Ochoa DC, Santillana JM, Skrobot SA, Castellarnau S, et al: The road to real zero ischemia for partial nephrectomy. J Endourol 2013;27:936-942.
14.
Salami SS, George AK, Rais-Bahrami S, Okhunov Z, Waingankar N, Kavoussi LR: Off-clamp laparoscopic partial nephrectomy for hilar tumors: oncologic and renal functional outcomes. J Endourol 2014;28:191-195.
15.
Simmons MN, Schreiber MJ, Gill IS: Surgical renal ischemia: a contemporary overview. J Urol 2008;180:19-30.
16.
Smith GL, Kenney PA, Lee Y, Libertino JA: Non-clamped partial nephrectomy: techniques and surgical outcomes. BJU Int 2011;107:1054-1058.
17.
Ficarra V, Novara G, Secco S, Macchi V, Porzionato A, De Caro R, et al: Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery. Eur Urol 2009;56:786-793.
18.
Waldert M, Waalkes S, Klatte T, Kuczyk MA, Weibl P, Schüller G, et al: External validation of the preoperative anatomical classification for prediction of complications related to nephron-sparing surgery. World J Urol 2010;28:531-535.
19.
Kobayashi K, Saito T, Kitamura Y, Nobushita T, Kawasaki T, Hara N, et al: The RENAL nephrometry score and the PADUA classification for the prediction of perioperative outcomes in patients receiving nephron-sparing surgery: feasible tools to predict intraoperative conversion to nephrectomy. Urol Int 2013;91:261-268.
20.
Dindo D, Demartines N, Clavien PA: Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205-213.
21.
Ljungberg B, Cowan NC, Hanbury DC, Hora M, et al: EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 2010;58:398-406.
22.
Van Poppel H, Da Pozzo L, Albrecht W, Matveev V, Bono A, Borkowski A, et al: A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 2011;59:543-552.
23.
Van Poppel H: Efficacy and safety of nephron-sparing surgery. Int J Urol 2010;17:314-326.
24.
Lesage K, Joniau S, Fransis K, Van Poppel H: Comparison between open partial and radical nephrectomy for renal tumours: perioperative outcome and health-related quality of life. Eur Urol 2007;51:614-620.
25.
Becker F, Van Poppel H, Hakenberg OW, Stief C, Gill I, et al: Assessing the impact of ischaemia time during partial nephrectomy. Eur Urol 2009;56:625-634.
26.
Novak R, Mulligan D, Abaza R: Robotic partial nephrectomy without renal ischemia. Urology 2012;79:1296-1301.
27.
Vittori G: Open versus robotic-assisted partial nephrectomy: a multicenter comparison study of perioperative results and complications. World J Urol 2014;32:287-293.
28.
Ficarra V, Minervini A, Antonelli A, Bhayani S, Guazzoni G, Longo N, et al: A multicentre matched-pair analysis comparing robot-assisted versus open partial nephrectomy. BJU Int 2014;113:936-941.
29.
Rosenbaum C, Wach S, Kunath F, Wullich B, Scholbach T, Engehausen DG: Dynamic tissue perfusion measurement: a new tool for characterizing renal perfusion in renal cell carcinoma patients. Urol Int 2013;90:87-94.
30.
Pignot G, Méjean A, Bernhard JC, Bigot P, Timsit MO, Ferriere JM, et al: The use of partial nephrectomy: results from a contemporary national prospective multicenter study. World J Urol 2015;33:33-40.
31.
Gill IS, Patil MB, Abreu AL, Ng C, Cai J, Berger A, et al: Zero ischemia anatomical partial nephrectomy: a novel approach. J Urol 2012;187:807-814.
32.
Borghesi M, Brunocilla E, Schiavina R, Martorana G: Positive surgical margins after nephron-sparing surgery for renal cell carcinoma: incidence, clinical impact, and management. Clin Genitourin Cancer 2013;11:5-9.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.